MENU
ABOS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Acumen Pharmaceuticals (ABOS) Earnings Date & Reports
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease... Show more
A.I. Advisor
published Earnings
ABOS is expected to report earnings to fall 4.44% to -43 cents per share on October 26
Q3'26
Est.
$-0.43
Q2'26
Missed
by $0.09
Q1'26
Beat
by $0.04
Q4'25
Beat
by $0.06
Q3'25
Beat
by $0.16
The last earnings report on August 12 showed earnings per share of -44 cents, missing the estimate of -36 cents. With 338.14K shares outstanding, the current market capitalization sits at 148.97M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
1210-1220 Washington Street
Phone
+1 617 344-4190
Employees
61
Web
https://www.acumenpharm.com